Cargando…

SARS‐CoV‐2‐related myocarditis‐like syndromes Shakespeare's question: what's in a name?

Detalles Bibliográficos
Autores principales:	Van Linthout, Sophie, Klingel, Karin, Tschöpe, Carsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd. 2020
Materias:	VIEWPOINTS AND COMMENTS
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276849/ https://www.ncbi.nlm.nih.gov/pubmed/32430971 http://dx.doi.org/10.1002/ejhf.1899

Ejemplares similares

Myeloid-Derived Suppressor Cells Restrain Natural Killer Cell Activity in Acute Coxsackievirus B3-Induced Myocarditis
por: Müller, Irene, et al.
Publicado: (2021)

Viral myocarditis: a prime example for endomyocardial biopsy-guided diagnosis and therapy
por: Van Linthout, Sophie, et al.
Publicado: (2018)

The Spontaneous Course of Human Herpesvirus 6 DNA-Associated Myocarditis and the Effect of Immunosuppressive Intervention
por: Elsanhoury, Ahmed, et al.
Publicado: (2022)

What's in a name?
por: Petsko, Gregory A
Publicado: (2002)

What’s in a name? Issues to consider when naming Mendelian disorders
por: Rasmussen, Sonja A., et al.
Publicado: (2020)

SARS-CoV-2 and COVID-19: revisiting the most important research questions
por: Yuen, Kit-San, et al.
Publicado: (2021)

Wearables in the SARS-CoV-2 Pandemic: What Are They Good for?
por: Bent, Brinnae, et al.
Publicado: (2020)

Toll-Like Receptors: Are They Taking a Toll on the Heart in Viral Myocarditis?
por: Favere, Kasper, et al.
Publicado: (2021)

SARS-CoV-2 vaccination in patients with liver disease: responding to the next big question
por: Marjot, Thomas, et al.
Publicado: (2021)

Long COVID in inflammatory rheumatic diseases—what's in a name?
por: Calabrese, Leonard H
Publicado: (2023)

Mesenchymal Stromal Cells Modulate Monocytes Trafficking in Coxsackievirus B3‐Induced Myocarditis
por: Miteva, Kapka, et al.
Publicado: (2017)

Mesenchymal Stromal Cells but Not Cardiac Fibroblasts Exert Beneficial Systemic Immunomodulatory Effects in Experimental Myocarditis
por: Savvatis, Konstantinos, et al.
Publicado: (2012)

Cardiac Fibroblasts Aggravate Viral Myocarditis: Cell Specific Coxsackievirus B3 Replication
por: Lindner, Diana, et al.
Publicado: (2014)

Who is most likely to be infected with SARS-CoV-2?
por: Jordan, Rachel E, et al.
Publicado: (2020)

Open questions: What is there left for cell biologists to do?
por: Munro, Sean
Publicado: (2013)

Open questions: what about the ‘other’ Rho GTPases?
por: Ridley, Anne J.
Publicado: (2016)

Open questions: what are the genes underlying antagonistic coevolution?
por: Ebert, Dieter
Publicado: (2018)

In the Gray Zone in the Fragile X Gene: What are the Key Unanswered Clinical and Biological Questions?
por: Hall, Deborah A.
Publicado: (2014)

Myocarditis and inflammatory cardiomyopathy: current evidence and future directions
por: Tschöpe, Carsten, et al.
Publicado: (2020)

Prescribing generics: All in a name
por: Roy, Vandana, et al.
Publicado: (2018)

Open questions: how does Wolbachia do what it does?
por: Jiggins, Francis M.
Publicado: (2016)

SARS-CoV-2 vaccine-induced antibody levels: what lies beneath
por: Lassaunière, Ria, et al.
Publicado: (2022)

Respiratory syncytial virus after the SARS-CoV-2 pandemic — what next?
por: Mosscrop, Lucy G., et al.
Publicado: (2022)

New Insights in (Inter)Cellular Mechanisms by Heart Failure with Preserved Ejection Fraction
por: Tschöpe, Carsten, et al.
Publicado: (2014)

Inflammation – Cause or Consequence of Heart Failure or Both?
por: Van Linthout, Sophie, et al.
Publicado: (2017)

Naming Genes for Dystonia: DYT-z or Ditzy?
por: Mencacci, Niccolo E., et al.
Publicado: (2019)

What is the vaccine effect on reducing transmission in the context of the SARS-CoV-2 delta variant?
por: Wilder-Smith, Annelies
Publicado: (2022)

Open questions: respiratory chain supercomplexes—why are they there and what do they do?
por: Hirst, Judy
Publicado: (2018)

“What’s in a name?”: Exploring inconsistent and contradictory definitions and clinical guidelines for hypertensive disorders of pregnancy from published literature from Nigeria and Bangladesh
por: Kirk, Karen, et al.
Publicado: (2020)

Deworming and Development: Asking the Right Questions, Asking the Questions Right
por: Bundy, Donald A. P., et al.
Publicado: (2009)

Epidemiological profiles of SARS-CoV and SARS-Cov-2 in Singapore and its promising containment strategies
por: Chaturvedi, Rini, et al.
Publicado: (2021)

Biologics, Pharmacovigilance, and Patient Safety: It’s All in the Name
por: Stevenson, James G., et al.
Publicado: (2016)

Attracting private sector inflows to close the financing gap for universal health coverage: What questions need to be answered?
por: Kwesiga, Brendan, et al.
Publicado: (2023)

Restoring indigenous names in taxonomy
por: Gillman, Len Norman, et al.
Publicado: (2020)

Recommendations for return to sport during the SARS-CoV-2 pandemic
por: Löllgen, Herbert, et al.
Publicado: (2020)

Mechanical Unloading by Fulminant Myocarditis: LV-IMPELLA, ECMELLA, BI-PELLA, and PROPELLA Concepts
por: Tschöpe, Carsten, et al.
Publicado: (2018)

Telbivudine in chronic lymphocytic myocarditis and human parvovirus B19 transcriptional activity
por: Van Linthout, Sophie, et al.
Publicado: (2018)

Protective Function of STAT3 in CVB3-Induced Myocarditis
por: Lindner, Diana, et al.
Publicado: (2012)

Evaluation of Lens culinaris phytochemicals in binding to the 3C-like protease of SARS-CoV-2 – A molecular docking approach
por: Hasan, Anamul, et al.
Publicado: (2020)

SARS-CoV-2: The Second Wave in Europe
por: Fokas, Athanassios S, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pip03f62fmeclct2dblaf3jjq0